Changes in Postmenopausal Hormone Replacement Therapy Use Among Women With High Cardiovascular Risk.

• Autores: Angela Hsu, Andrea Card, Susan Xiaoqin Lin, Sean Mota, Olveen Carrasquillo, Andrew Moran
• Localización: American journal of public health, ISSN 0090-0036, Vol. 99, Nº. 12, 2009, págs. 2184-2187
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • After randomized trials failed to support the use of hormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausal women declined. Our analysis of 1999-2000 and 2003-2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P<.001) among women with CVD versus 3% (from 19.8 to 16.8%; P= .68) among low-risk women, suggesting that most of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD. [ABSTRACT FROM AUTHOR]